Bioelectronics Corp (BIEL)

[kidnova]

If/when they execute a reverse split will be dependent on how the PPS reacts to events over the next few months. If dilution and FDA events force the PPS down to a level that BIEL cannot effectively fund operations through the issuance of shares then they will have no choice but to conduct a reverse split. On the other hand, if FDA news is favorable the and PPS climbs then there will be no reason to conduct one in the near term.